1,2-naphthoquinone has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, N; Chinen, T; Ciftci, H; Fujita, M; Inoue, JI; Iwamaru, K; Koga, R; Nakagawa, R; Otsuka, M; Radwan, MO; Tateishi, H; Toma, T; Tominaga, Y; Umezawa, K | 1 |
| Bian, J; Fan, J; Gu, J; Li, S; Li, X; Mu, T; Qian, X; Sun, H; Wang, N; Yang, T; Yang, X; You, Q; Zhang, X | 1 |
2 other study(ies) available for 1,2-naphthoquinone and Lung Neoplasms
| Article | Year |
|---|---|
A New 1,2-Naphthoquinone Derivative with Anti-lung Cancer Activity.
Topics: Apoptosis; Humans; Lung Neoplasms; Naphthoquinones; NF-kappa B | 2022 |
Novel naphtho[2,1-d]oxazole-4,5-diones as NQO1 substrates with improved aqueous solubility: Design, synthesis, and in vivo antitumor evaluation.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Humans; Lung; Lung Neoplasms; Mice; Mice, Nude; Molecular Docking Simulation; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; Solubility; Water | 2016 |